lactic acid has been researched along with mart-1 antigen in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaubal, VA; Mojamdar, MV; Nair, SS | 1 |
| Bouvet, M; Chen, M; Grotjahn, D; Ichim, T; Kaushal, S; Kruse, C; Ma, W; McElroy, M; Minev, B; Ozkan, C; Zhang, Y | 1 |
| Edelson, RL; Fahmy, TM; Hanlon, DJ; Hong, E; Khalil, D; Robinson, E; Saluja, SS; Sharp, FA; Tigelaar, R | 1 |
| Burner, D; Cai, J; Chen, Q; Li, H; Lu, L; Ma, W; Minev, B; Shao, S | 1 |
4 other study(ies) available for lactic acid and mart-1 antigen
| Article | Year |
|---|---|
Type I gamma-GT mRNA is expressed in B16 melanoma and levels correlate with pigmentation.
Topics: Animals; Antigens, Neoplasm; Base Sequence; gamma-Glutamyltransferase; Gene Expression Regulation, Enzymologic; Humans; Lactic Acid; MART-1 Antigen; Melanins; Melanoma, Experimental; Molecular Sequence Data; Monophenol Monooxygenase; Neoplasm Proteins; Peptides; Phenotype; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 2002 |
PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses.
Topics: Animals; Antigen Presentation; Antigens, Neoplasm; Cancer Vaccines; Cell Line, Tumor; Dendritic Cells; Drug Delivery Systems; Humans; Injections, Intraperitoneal; Lactic Acid; Male; MART-1 Antigen; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Nanomedicine; Nanoparticles; Nanotechnology; Neoplasms, Experimental; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostatic Neoplasms; T-Lymphocytes, Cytotoxic | 2012 |
Targeting human dendritic cells via DEC-205 using PLGA nanoparticles leads to enhanced cross-presentation of a melanoma-associated antigen.
Topics: Antigen Presentation; Antigens, CD; Cancer Vaccines; Dendritic Cells; Humans; Lactic Acid; Lectins, C-Type; MART-1 Antigen; Melanoma; Minor Histocompatibility Antigens; Molecular Targeted Therapy; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Receptors, Cell Surface | 2014 |
Artificial human antigen-presenting cells are superior to dendritic cells at inducing cytotoxic T-cell responses.
Topics: Antigen Presentation; Cancer Vaccines; Cell Survival; Cytotoxicity, Immunologic; Delayed-Action Preparations; Dendritic Cells; Drug Compounding; Drug Liberation; Humans; Inhibitor of Apoptosis Proteins; Kinetics; Lactic Acid; Lipopolysaccharides; MART-1 Antigen; MCF-7 Cells; Nanoparticles; Neoplasms; Peptide Fragments; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Survivin; T-Lymphocytes, Cytotoxic | 2017 |